CBFB/MYH11 gene fusion probe, CBFB/MYH11
Catalog No : FP-028
513.00€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
| Product name | CBFB/MYH11 gene fusion probe, CBFB/MYH11 | ||
|---|---|---|---|
| Catalog No | FP-028 | ||
| Supplier’s Catalog No | FP-028 | ||
| Supplier | Wuhan Healthcare Biotech | ||
| Source antigen | CBFB | ||
| Reactivity | CBFB/MYH11 | ||
| Cross reactivity | None | ||
| Applications | Fluorescence In Situ Hybridization (FISH) | ||
| Molecular weight | N/A | ||
| Storage | -20°C | ||
|---|---|---|---|
| Other names | |||
| Grade | Molecular diagnostic grade | ||
| Purity | N/A | ||
| Form | Liquid | ||
| Reactivity life | 12 months when stored properly according to instructions | ||
| Note | For Research purpose only | ||
| Description | The CBFB/MYH11 gene fusion can be used for the diagnosis of AML. In addition, for the CBFB/MYH11 gene positive fusion case, the detection of the fusion gene is also the most valuable indicator for the determination of the treatment plan and the evaluation of the efficacy, such as CBFB. Quantitative analysis of the /MYH11 fusion gene can also be used to judge the level of leukemia cells in patients, the detection of minimal residual disease and the risk of recurrence. Patients with AML patients with CBFB/MYH11 gene fusion have a better prognosis, and high DFS and low recurrence rates can be achieved with HDAC. | ||
Product Details
© 2020 Imugex All Rights Reserved